Skip to main content Accessibility help

Prevalence of pharyngeal and laryngeal complications in adult asthmatics using inhaled corticosteroids

  • R K Bhalla (a1), A S Jones (a1) and N J Roland (a1)



To investigate the prevalence in adults of pharyngeal and laryngeal symptoms associated with the use of inhaled corticosteroids.


Prospective, observational and based on a structured, specifically designed postal questionnaire.


University Hospital Aintree, Liverpool, UK.


The questionnaire was distributed to 190 patients on the basis of current inhaled corticosteroid use. Recruitment was from the databases of two local general practices. Individuals were classified as mild, moderate or severe asthmatics, using the guidelines of the British Thoracic Society.

Main outcome measures:

Demographic data, including smoking history, were recorded. The number, type, strength, dosing regime and duration of individual inhaler use were recorded. Specific pharyngeal and laryngeal side effects were enquired about. Co-morbidities and preventive measures were also recorded. Results were analysed using univariate and multivariate statistical tests.


There was a 75.8 per cent response rate (144/190 questionnaires); 63 (43.8 per cent) of respondents were male and 81 (56.2 per cent) were female. The majority of our patients were either mild or moderate asthmatics. Longer use of an inhaled corticosteroid predisposed to weak voice (p = 0.0016), hoarseness (p = 0.0001) and throat irritation (p = 0.008). Hoarseness, throat irritation, sore throat and cough were observed much more frequently than anticipated. Severe asthmatics were more likely to use a spacer device compliantly (p = 0.0487; odds ratio 1.53). Side effects were more prevalent as asthma severity worsened (p = 0.0049; odds ratio 1.87).


Inhaled corticosteroids cause sore throats, throat irritation, hoarseness and cough. Further research in this area is required in order to elucidate the mechanism of inflammation. Only then can effective preventive measures be introduced and implemented.


Corresponding author

Address for correspondence: Mr R K Bhalla, 17 Withins Hall Road, Woodhouses, Manchester M35 9SA, UK. Fax: +44 (0)151 529 5263 E-mail:


Hide All
1 The use of inhaled corticosteroids in adults with asthma. Drug Ther Bull 2000;38:58
2 Toogood, JH, Crilly, RG, Jones, G, Nadeau, J, Wells, GA. Effect of high-dose inhaled Budesonide on calcium and phosphate metabolism and the risk of osteoporosis. Am Rev Respir Dis 1988;138:5761
3 Packe, GE, Douglas, JG, McDonald, AF, Robins, SP, Reid, DM. Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids. Thorax 1992;47:414–17
4 Maxwell, DL. Adverse effects of inhaled corticosteroids. Biomed Pharmacother 1990;44:421–7
5 Hanania, NA, Chapman, KR, Kesten, S. Adverse effects of inhaled corticosteroids. Am J Med 1995;98:196208
6 Capewell, S, Reynolds, S, Shuttleworth, D, Edwards, C, Finlay, AY. Purpura and dermal thinning associated with high dose inhaled corticosteroids. Br Med J 1990;300:1548–51
7 Mak, VH, Melchor, R, Spiro, SG. Easy bruising as a side effect of inhaled corticosteroids. Eur Respir J 1992;5:1068–74
8 Cumming, RG, Mitchell, P, Leeder, SR. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med 1997;337:814
9 Garbe, E, LeLorier, J, Boivin, J-F, Suissa, S. Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. J Am Med Assoc 1997;277:722–7
10 Roland, NJ, Bhalla, RK, Earis, J. The local side effects of inhaled corticosteroids: current understanding and review of the literature. Chest 2004;126:213–19
11 Babu, S, Samuel, P. The effect of inhaled steroids on the upper respiratory tract. J Laryngol Otol 1988;102:592–4
12 Barnes, PJ, Pedersen, S, Busse, WW. Efficacy and safety of inhaled corticosteroids. Am J Respir Crit Care Med 1998;157 (3 pt 2):S153
13 Held, E, Ottervanger, V, Petersen, S, Weismann, K. Perioral dermatitis in children under steroid inhalation therapy [in Danish]. Ugeskr Laeger 1997;157:7002–3
14 Linder, N, Kuint, J, German, B, Lubin, D, Loewenthal, R. Hypertrophy of the tongue associated with inhaled steroid therapy in premature infants. J Paediatrics 1995;127:651–3
15 Williams, AJ, Baghat, MS, Stableforth, DE, Cayton, RM, Shenoi, PM, Skinner, C. Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality. Thorax 1983;38:813–21
16 DelGaudio, JM. Steroid inhaler laryngitis: dysphonia caused by inhaled fluticasone therapy. Arch Otolaryngol Head Neck Surg 2002;128:677–81
17 Williamson, IJ, Matusiewicz, SP, Brown, PH, Greening, AP, Crompton, GK. Frequency of voice problems and cough in patients using pressurised aerosol steroid preparations. Eur Respir J 1995;8:590–2
18 British Thoracic Society. British guideline on the management of asthma. Thorax 2003;58(suppl 1):20–4
19 SAS Institute Inc. [8.2] User's Guide: Statistics Version, 5th edn. Cary, NC: SAS Institute Inc, 1985
20 Selroos, O, Backman, R, Forsen, KO, Lofroos, AB, Niemisto, M, Pietinalho, A et al. Local side effects during 4-year treatment with inhaled corticosteroids – a comparison between pressurised metered-dose inhalers and Turbohaler. Allergy 1994;49:888–90
21 Lipworth, BJ. New perspectives on inhaled drug delivery and systemic bioactivity. Thorax 1995;50:105–10
22 Inhaler devices for asthma. Drug Ther Bull 2000;38:914
23 Bryant, DH, Pepys, J. Bronchial reactions to aerosol inhalant vehicle. Br Med J 1976;1:1319–20
24 Shim, C, Williams, MH. Cough and wheezing from beclomethasone aerosol. Chest 1987;91:207–9
25 Currie, GP, McLaughlin, K. The expanding role of leukotriene receptor antagonists in chronic asthma. Ann Allergy Asthma Immunol 2006;97:731–41


Prevalence of pharyngeal and laryngeal complications in adult asthmatics using inhaled corticosteroids

  • R K Bhalla (a1), A S Jones (a1) and N J Roland (a1)


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed